Lv4
604 积分 2025-06-15 加入
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
1个月前
已完结
Impact of cardiometabolic risk factors on hepatic fibrosis and clinical outcomes in MASLD: A population-based multi-cohort study
2个月前
已完结
Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea
2个月前
已完结
The challenge of defining metabolic dysfunction and alcohol-associated liver disease
4个月前
已完结
Liver‐Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac Dysfunction
4个月前
已完结
Editorial: Combination Therapies for MASH : A Step Forward or More Complexity?
4个月前
已完结
Trends in the Prevalence of Clinical and Preclinical Obesity Among US Adults by Social Determinants of Health
4个月前
已完结
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
4个月前
已完结
皖公网安备34019202002308
